Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Landis, K. Wurst, H. Le, H. Muellerova, K. Davis (Uxbridge, United Kingdom; Research Triangle Park, United States Of America; Wavre, Belgium). Characteristics of patients newly prescribed a long acting bronchodilator in the United Kingdom (UK). Eur Respir J 2014; 44: Suppl. 58, 1074

Member's Comments

No comment yet.

Related content which might interest you: Characteristics of patients newly prescribed a long acting bronchodilator in the US Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013 Asthma ICs prescriptions in primary care in France and the United Kingdom: Are they similar? Source: International Congress 2016 – Asthma management in primary care Year: 2016 The DACCORD study: Real-life COPD outpatient treatment with long-acting bronchodilators in Germany Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013 Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Astro-Lab project: Assessment of the safety of long-acting beta agonists (LABAs) in asthma by combining health-care databases and direct patient follow-up: Description of the patient pattern in France and in the United-Kingdom (UK) Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013 LATE-BREAKING ABSTRACT: The use of benzodiazepines in COPD: A population-based study of Norway Source: Annual Congress 2013 –Highlights in epidemiology of respiratory disease Year: 2013 Long-acting anti-muscarinic agents (LAMA) frequency of use and clinical features of patients with severe asthma in real-life setting: data from the Severe Asthma Network in Italy (SANI) registry Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019 The effect of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A real practice analysis in Italy Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014 Prescribing patterns for UK patients commencing first maintenance therapy for COPD Source: International Congress 2014 – COPD markers Year: 2014 Drug treatment in a German real-life COPD cohort (DACCORD) Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 A new user cohort study comparing the risk of pneumonia in inhaled corticosteroid (ICS) vs. long-acting bronchodilator (LABD) regimens in COPD Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Economic outcomes in the United States of treating COPD with inhaled corticosteroids and long-acting β-agonists in a managed care setting Source: Eur Respir J 2003; 22: Suppl. 45, 216s Year: 2003 The clinical impact of long-acting bronchodilators in newly diagnosed COPD patients Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 Changes in prescriped inhaled COPD medication during a 3 year period in Denmark. A registry study Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013 Use of long acting bronchodilators and inhaled corticosteroids within 30-days of discharge in older adults hospitalized for AECOPD Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Statin use and risk of exacerbations in individuals with COPD: The Copenhagen general population study Source: International Congress 2014 – New insights into the epidemiology of COPD Year: 2014 Assessment of factors influencing adherence to asthma treatment among 12-17 year olds: A multi-national survey in France, Germany, Spain and United Kingdom Source: International Congress 2016 – Asthma management in primary care Year: 2016 Canadian physicians are concerned about the use of inhaled corticosteroids (ICS) in COPD management Source: International Congress 2014 – Management of asthma and other respiratory diseases in primary care Year: 2014 Hospital resource use for COPD patients varies by both clinical commissioning group and primary care practices across nine CCGs in the United Kingdom Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015 Changes in the treatment of asthma in Spain in the last twenty years. A population based study (ECRHS) Source: International Congress 2014 – Epidemiology of asthma Year: 2014